A different surgery path saved a woman's sight during brain tumor surgery
Original title: Extreme Lateral Supracerebellar Infratentorial Approach for Petroclival Meningioma with an Ophthalmic Artery Originating from the Middle Meningeal Artery: Illustrative Case.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This was done in one patient and written up as a single case, not tested in a study.
The short version
Doctors took an unusual route to reach a deep brain tumor so the patient would not go blind.
What was studied. This is a report on one patient, a 46-year-old woman with a meningioma at the base of her skull. She also had face pain. Scans of her blood vessels before surgery showed a rare pattern: the artery that feeds her eye came off a vessel the usual surgery would have to cut.
What they found. Because the usual route risked permanent blindness, the team came in from the side and below instead. Doctors removed part of the tumor, but not all of it. The rest was stuck to the brain stem and nearby blood vessels. She had weakness and eye trouble after surgery that cleared within 3 months. The tumor grew again at 13 months and was treated with focused radiation. She was stable at 3 years.
What this means, and what it doesn't
What it could mean: Her eyesight was protected, and she was still doing well 3 years later. It shows why doctors check the blood vessels with scans before this kind of surgery. If your tumor sits in a hard place, it is fair to ask your surgeon how they plan to get to it.
What it doesn't mean: This is one person's story, not a study. One good result does not prove this route is better or safer for other people. The surgeons say it takes rare skill and does not reach every part of the skull base. Part of her tumor was left behind, and it grew back. This is not a cure and not a promise.
Source: PubMed, October 13, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.